PRKN and esophageal squamous cell carcinoma: Immunochemistry study revealed that PARK2 expression was low in human ESCC samples and reversely correlated with Yap expression, and TCGA data analysis indicated that high PARK2 expression correlated with good prognosis in ESCC patients (Zhou et al., 2020).